Johnson & Johnson is officially seeking emergency use authorization from the FDA for its COVID-19 booster in people 18 and older.
Johnson & Johnson says a booster dose increases protection to 94% against moderate to severe COVID-19 reactions. Its data also suggests antibody levels increase nine-fold one week after a booster is administered. That number climbs to 12-fold higher four weeks after the booster.
An FDA advisory committee will meet next week to discuss authorizing its booster along with Moderna's. But we know there’s still a lot of questions out there about boosters, so we're answering some of the questions we get asked the most.
READ MORE: [ Ссылка ]
